Cargando…

Prognosis and long-term neurodevelopmental outcome in conservatively treated twin-to-twin transfusion syndrome

BACKGROUND: Amnioreduction remains a treatment option for pregnancies with twin-to-twin transfusion syndrome (TTTS) not meeting criteria for laser surgery or those in which it is not feasible. Amnioreduction is a relatively simple treatment which does not require sophisticated technical equipment. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiangqun, Morokuma, Seiichi, Fukushima, Kotaro, Otera, Yuka, Yumoto, Yasuo, Tsukimori, Kiyomi, Ochiai, Masayuki, Hara, Toshiro, Wake, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125386/
https://www.ncbi.nlm.nih.gov/pubmed/21510908
http://dx.doi.org/10.1186/1471-2393-11-32
_version_ 1782207221186166784
author Li, Xiangqun
Morokuma, Seiichi
Fukushima, Kotaro
Otera, Yuka
Yumoto, Yasuo
Tsukimori, Kiyomi
Ochiai, Masayuki
Hara, Toshiro
Wake, Norio
author_facet Li, Xiangqun
Morokuma, Seiichi
Fukushima, Kotaro
Otera, Yuka
Yumoto, Yasuo
Tsukimori, Kiyomi
Ochiai, Masayuki
Hara, Toshiro
Wake, Norio
author_sort Li, Xiangqun
collection PubMed
description BACKGROUND: Amnioreduction remains a treatment option for pregnancies with twin-to-twin transfusion syndrome (TTTS) not meeting criteria for laser surgery or those in which it is not feasible. Amnioreduction is a relatively simple treatment which does not require sophisticated technical equipment. Previous reports of conservative management have indicated that major neurodevelopmental impairment occurs in 14.3-26% of survivors. The purpose of this study was to investigate long-term neurodevelopmental outcome in conservatively treated TTTS. METHODS: During the nine-year study period from January 1996 to December 2004, all pregnancies with TTTS who were admitted to our center were investigated. TTTS was diagnosed by using standard prenatal ultrasound criteria, and staged according to the criteria of Quintero et al. We reviewed gestational age at diagnosis, gestational age at delivery, the stage of TTTS at diagnosis, and diagnosis to delivery interval. Neonatal cranial ultrasound findings were reviewed and the neurodevelopmental outcomes were evaluated. RESULTS: Twenty-one pregnancies with TTTS were included. Thirteen pregnancies (62%) were treated with serial amnioreduction. The mean gestational age at delivery was 28 weeks (22 - 34 weeks). The perinatal mortality rate was 42.9%. Twenty survivors were followed up until at least 3 years of age. The mean age at follow-up was 6.3 years (3 - 12 years). Six children (30%) had neurodevelopmental impairment. Four children (20%) had major neurodevelopmental impairment and two children (10%) had minor neurodevelopmental impairment. Children with neurodevelopmental impairment were delivered before 29 weeks of gestation. CONCLUSIONS: Our study showed a high rate of perinatal mortality and a high rate of major neurodevelopmental impairment in conservatively treated TTTS. The long-term outcomes for the survivors with TTTS were good when survivors were delivered after 29 weeks of gestation.
format Online
Article
Text
id pubmed-3125386
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31253862011-06-29 Prognosis and long-term neurodevelopmental outcome in conservatively treated twin-to-twin transfusion syndrome Li, Xiangqun Morokuma, Seiichi Fukushima, Kotaro Otera, Yuka Yumoto, Yasuo Tsukimori, Kiyomi Ochiai, Masayuki Hara, Toshiro Wake, Norio BMC Pregnancy Childbirth Research Article BACKGROUND: Amnioreduction remains a treatment option for pregnancies with twin-to-twin transfusion syndrome (TTTS) not meeting criteria for laser surgery or those in which it is not feasible. Amnioreduction is a relatively simple treatment which does not require sophisticated technical equipment. Previous reports of conservative management have indicated that major neurodevelopmental impairment occurs in 14.3-26% of survivors. The purpose of this study was to investigate long-term neurodevelopmental outcome in conservatively treated TTTS. METHODS: During the nine-year study period from January 1996 to December 2004, all pregnancies with TTTS who were admitted to our center were investigated. TTTS was diagnosed by using standard prenatal ultrasound criteria, and staged according to the criteria of Quintero et al. We reviewed gestational age at diagnosis, gestational age at delivery, the stage of TTTS at diagnosis, and diagnosis to delivery interval. Neonatal cranial ultrasound findings were reviewed and the neurodevelopmental outcomes were evaluated. RESULTS: Twenty-one pregnancies with TTTS were included. Thirteen pregnancies (62%) were treated with serial amnioreduction. The mean gestational age at delivery was 28 weeks (22 - 34 weeks). The perinatal mortality rate was 42.9%. Twenty survivors were followed up until at least 3 years of age. The mean age at follow-up was 6.3 years (3 - 12 years). Six children (30%) had neurodevelopmental impairment. Four children (20%) had major neurodevelopmental impairment and two children (10%) had minor neurodevelopmental impairment. Children with neurodevelopmental impairment were delivered before 29 weeks of gestation. CONCLUSIONS: Our study showed a high rate of perinatal mortality and a high rate of major neurodevelopmental impairment in conservatively treated TTTS. The long-term outcomes for the survivors with TTTS were good when survivors were delivered after 29 weeks of gestation. BioMed Central 2011-04-22 /pmc/articles/PMC3125386/ /pubmed/21510908 http://dx.doi.org/10.1186/1471-2393-11-32 Text en Copyright ©2011 Li et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Xiangqun
Morokuma, Seiichi
Fukushima, Kotaro
Otera, Yuka
Yumoto, Yasuo
Tsukimori, Kiyomi
Ochiai, Masayuki
Hara, Toshiro
Wake, Norio
Prognosis and long-term neurodevelopmental outcome in conservatively treated twin-to-twin transfusion syndrome
title Prognosis and long-term neurodevelopmental outcome in conservatively treated twin-to-twin transfusion syndrome
title_full Prognosis and long-term neurodevelopmental outcome in conservatively treated twin-to-twin transfusion syndrome
title_fullStr Prognosis and long-term neurodevelopmental outcome in conservatively treated twin-to-twin transfusion syndrome
title_full_unstemmed Prognosis and long-term neurodevelopmental outcome in conservatively treated twin-to-twin transfusion syndrome
title_short Prognosis and long-term neurodevelopmental outcome in conservatively treated twin-to-twin transfusion syndrome
title_sort prognosis and long-term neurodevelopmental outcome in conservatively treated twin-to-twin transfusion syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125386/
https://www.ncbi.nlm.nih.gov/pubmed/21510908
http://dx.doi.org/10.1186/1471-2393-11-32
work_keys_str_mv AT lixiangqun prognosisandlongtermneurodevelopmentaloutcomeinconservativelytreatedtwintotwintransfusionsyndrome
AT morokumaseiichi prognosisandlongtermneurodevelopmentaloutcomeinconservativelytreatedtwintotwintransfusionsyndrome
AT fukushimakotaro prognosisandlongtermneurodevelopmentaloutcomeinconservativelytreatedtwintotwintransfusionsyndrome
AT oterayuka prognosisandlongtermneurodevelopmentaloutcomeinconservativelytreatedtwintotwintransfusionsyndrome
AT yumotoyasuo prognosisandlongtermneurodevelopmentaloutcomeinconservativelytreatedtwintotwintransfusionsyndrome
AT tsukimorikiyomi prognosisandlongtermneurodevelopmentaloutcomeinconservativelytreatedtwintotwintransfusionsyndrome
AT ochiaimasayuki prognosisandlongtermneurodevelopmentaloutcomeinconservativelytreatedtwintotwintransfusionsyndrome
AT haratoshiro prognosisandlongtermneurodevelopmentaloutcomeinconservativelytreatedtwintotwintransfusionsyndrome
AT wakenorio prognosisandlongtermneurodevelopmentaloutcomeinconservativelytreatedtwintotwintransfusionsyndrome